Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
PharmaMar and Chugai Pharmaceutical Enter into a License and Commercialization Agreement
Friday, December 23, 2016PharmaMar has announced today the signing of an exclusive license development and commercialization agreement with Chugai Pharmaceutical Co Ltd TSE for its third marinederived anticancer drug PM lurbinectedin in Japan Under the terms of this agreeme...
Roche’s emicizumab for haemophilia A meets primary endpoint in phase III study
Friday, December 23, 2016Roche announced that the primary endpoint has been met for the phase III HAVEN study evaluating emicizumab prophylaxis in people years of age or older with haemophilia A and inhibitors to factor VIII The study showed a statistically significant red...
Dipexium Pharmaceuticals and PLx Pharma Announce Merger Agreement
Friday, December 23, 2016Dipexium Pharmaceuticals Inc and PLx Pharma Inc a privately held latestage specialty pharmaceutical company announced today that they have entered into a definitive agreement under which PLx Pharma will merge with a whollyowned subsidiary of Dipexium...
Novartis out-licenses three COPD products in the US
Thursday, December 22, 2016Novartis announced that it has signed a licensing agreement with Sunovion Pharmaceuticals Inc Sunovion for the US commercial rights to its three treatments for chronic obstructive pulmonary disease COPD Utibron Neohaler indacaterolglycopyrrolate inha...
Concert Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating CTP-656
Thursday, December 22, 2016Concert Pharmaceuticals Inc announced the initiation of a USbased Phase clinical trial evaluating CTP deuterated ivacaftor a next generation CFTR potentiator being developed for the treatment of cystic fibrosis CTP was created based on Concerts appl...
Incyte and Merus Entered into Research Collaboration to Discover and Develop Bispecific Antibodies
Thursday, December 22, 2016Incyte Corporation and Merus NV announced that they have entered into a global strategic collaboration agreement focused on the research discovery and development of bispecific antibodies utilizing Merus proprietary Biclonics technology platform The...
X-Chem Entered into Multi-Target Drug Discovery Collaboration with Taiho Pharmaceutical
Wednesday, December 21, 2016XChem Inc a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics today announced that it entered into a multitarget drug discovery collaboration wit...
Soligenix Advances Collaboration with IDT Biologika
Wednesday, December 21, 2016Soligenix Inc a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need announced today that it has extended its collaboration with IDT Biologika hereafter ref...
Allergan to Acquire Acelity L.P. Inc.'s LifeCell Corporation for $2.9 Billion
Wednesday, December 21, 2016Allergan plc a leading global biopharmaceutical company and Acelity today announced that they have entered into a definitive agreement under which Allergan has agreed to acquire the regenerative medicine company LifeCell for billion in cash subject...
FDA Orphan Drug Designation Granted to Profounda Inc. for the treatment of Acanthamoeba Keratitis with miltefosine
Tuesday, December 20, 2016Profounda Inc Profounda announced that it has received the US Food and Drug Administrations FDA Orphan Drug Designation for the treatment of Acanthamoeba Keratitis with miltefosine Profounda licensed miltefosine Impavido from Knight Therapeutics USA...
